Abstract
The Human Genome Project—a three billion dollar, fifteen year effort to map and sequence the human genome1—was begun in 1990 and is presently estimated to be ahead of schedule. The base-pair by base-pair sequencing of the entire three billion bases of the human genome is within reach within the next five years. The phenomenal success of the project in meeting and surpassing its goals is largely due to advances in sequencing technologies and informatics. Indeed, the standard genomic sequencing technologies are largely automated and computer assisted (Gibbs, 1995). In addition, the analysis of raw genetic sequence, and its integration with maps of the various chromosomes is largely a project in informatics, the results of which are freely available over the World Wide Web. The purposes of this massive, industrial strength science project, are manifold. Besides providing the building blocks for answering questions about the ontogeny of the human organism, how the human species has diverged both from its evolutionary precursors as well as how individual races and ethnic groups have diverged genetically2, the Human Genome Project promises to revolutionize the practice of medicine and is already revolutionizing the strategies of biomedical research (Watson, 1992).3 It is this latter promise that is probably the most compelling reason that the United States Congress was willing to invest $200 million a year in this project.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
References
Anderson, C. (1993), ‘Genome Project Goes Commercial. [News]’, Science, Vol. 259,No. 5093, 15 Jan, pp. 300–302.
Annas, G.J. (1990), ‘Outrageous Fortune: Selling Other People’s Cells’, Hastings Center Report, Vol. 20,No. 6, pp. 36–39.
Annas, George J. (1993), ‘Privacy Rules for DNA Databanks: Protecting Coded ‘Future Diaries’’, Journal of the American Medical Association, Vol. 270,No. 19, 17 November, pp. 2346–2350.
Annas, George J.; Glantz, Leonard H.; Roche, Patricia A. (1995), ‘The Genetic Privacy Act and Commentary’ Boston University School of Public Health, Boston.
Anonymous (1996), ‘Gene Donors’ Rights at Risk’, Nature, Vol. 381, p. 1.
Anonymous (1996), ‘Capitalizing on the Genome [editorial]’, Nature Genetics, Vol. 13,No. 1, May, pp. 1–5.
Capron, Alexander M. (1991), ‘Protection of Research Subjects: Do Special Rules Apply in Epidemiology?’, Journal of Clinical Epidemiology, Vol. 44, pp. 81s–89s.
Clarke, Angus (1991), ‘Is Non-directive Genetic Counseling Possible?’, Lancet, Vol. 338, pp. 998–1001.
Cook-Deegan, R. (1994), ‘The Gene Wars: Science, Politics, and the Human Genome Project’ W. W. Norton, New York.
Dahm, Lisa L. (1997), ‘Using the DNA Profile as the Unique Patient Identifier in the Community Health Information Network: Legal Implications’, The John Marshall Journal of Computer & Information Law, Vol. 15,No. 2, Winter, pp. 227–275.
Decruyenaere, Marleen; Evers-Kiebooms, Gerry; Van den Berghe, Herman (1993), ‘Perception of Predictive Testing for Huntington’s Disease by Young Women: Preferring Uncertainty to Certainty?’, Journal of Medical Genetics, Vol. 30, pp. 557–561.
Drmanac, Radoje; Labat, Ivan; Brukner, Ivan; Crkvenjakov, Radomir (1989), ‘Sequencing of Megabase Plus DNA by Hybridization: Theory of the Method’, Genomics, Vol. 4, pp. 114–128.
Edelstein, Ludwig (1943), ‘The Hippocratic Oath: Text, Translation and Interpretation’, Supplement to the Bulletin of the Histoiy of Medicine, Vol. 1, p. 3.
Fersko, R.S.; Connolly, M.J. (1992), ‘Intellectual Property Issues in a Clinical Trial: A Corporate Perspective’, Quality Assurance, Vol. 1,No. 3, June, pp. 237–248.
Fisher, Lawrence M. (1996), ‘Cancer-Research Venture Announced’, New York Times, 21 August, p. C6.
Fodor, Stephen P.A.; Read, J.Leighton; Pirrung, Michael C; Stryer, Lubert; Lu, Amy Tsai; Solas, Dennis (1991), ‘Light-Directed, Spatially Addressable Parallel Chemical Synthesis’, Science, Vol. 251, pp. 767–773.
Giardiello, Francis M.; Brensinger, Jill D.; Brensinger, Jill D.; Peterson, Gloria M.; et al. (1997), ‘The Use and Interpretation of Commercial APC Gene Testing for Familial Adenomatous Polyposis’, The New England Journal of Medicine, Vol. 336,No. 12, 20 March, pp. 823–827.
Gibbs, Richard A. (1995), ‘Pressing Ahead with Human Genome Sequencing’, Nature Genetics, Vol. 11,No. 2, October, pp. 121–125.
Gilbert, Walter (1992), ‘A Vision of the Grail’ Kevles; in Hood, Daniel J. Leroy (ed.), The Code of Codes: Scientific and Social Issues in the Human Genome Project Harvard University Press, Cambridge, pp. 83–97.
Greely, Henry T. (1995), ‘Conflicts in the Biotechnology Industry’, Journal of Law, Medicine and Ethics, Vol. 23,No. 4, Winter, pp. 354–359.
Green, Mark (1996b), Compromising Your Drug of Choice: How HMOs are Dictating Your Next Prescription Office of the Public Advocate for the City of New York, New York.
Green, Mark (1996a), What Ails HMOs Office of the Public Advocate for the City of New York.
Hilts, Philip J. (1997), ‘Researcher Profited After Study by Investing in Cold Treatment’, New York Times, 1 February, p. A6.
Hubbard, Ruth; Wald, Elijah (1993), Exploding the Gene Myth Beacon Press, Boston.
Hudson, Kathy L.; Rothenberg, Karen H.; Andrews, Lori B.; Kahn, Mary Jo Ellis; Collins, Francis S. (1995), ‘Genetic Discrimination and Health Insurance: An Urgent Need for Reform’, Science, Vol. 270, pp. 391–393.
Huggins, Marlene; Bloch, Maurice; Kanani, Shelin; Quarrell, Oliver W.J.; Theilman, Jane; Hedrick, Amy; Dickens, Bernard; Lynch, Abbyan; Hayden, Michael (1990), ‘Ethical and Legal Dilemmas Arising During Predictive Testing for Adult-Onset Disease: The Experience of Huntington Disease’, American Journal of Human Genetics, Vol. 47, pp. 4–12.
Kolata, Gina (1995), ‘When Patients’ Records are Commodities for Sale’, New York Times, 15 November, pp. A1, C14.
Kolata, Gina (1996), ‘Breaking Ranks, Lab Offers Test Assessing Cancer Risk’, New York Times, 1 April, p. A1.
Koshland, Daniel (1989), ‘Sequences and Consequences of the Human Genome’, Science, Vol. 246, p. 189.
Kozal, Michael J.; Shah, Nila; Shen, Naiping; Yang, Robert; Fucini, Raymond; Merigan, Thomas C; Richman, Douglas D.; Morris, Don; Hubbell, Earl; Chee, Mark; Gingeras, Thomas R. (1996), ‘Extensive Polymorphisms Observed in HIV-1 Clade B Protease Gene Using High-Density Oligonucleotide Arrays’, Nature Medicine, Vol. 2,No. 7, pp. 753–759.
Lewontin, R.C. (1992), ‘The Dream of the Human Genome’, New York Review of Books, 19 November, pp. 31–40.
Lockhart, D.J.; Dong, H.; Byrne, M.C.; Follettie, M.T.; Gallo, M.V.; Chee, M.S.; Mittmann, M.; Wang, C; Kobayashi, M.; Horton, H.; Brown, E.L. (1996), ‘Expression Monitoring by Hybridization to High-Density Oligonucleotide Arrays’, Nature Biotechnology, Vol. 14, pp. 1675–1680.
McNally, Ruth; Wheale, Peter (1996), ‘Biopatenting and Biodiversity’, The Ecologist, Vol. 26,No. 5, pp. 222–228.
Nelkin, D.; Lindee, M.S. (1995) The DNA mystique: The gene as a cultural icon W. H. Freeman and Company, New York.
OMIM (1996), Online Mendelian Inheritance in Man Center for Medical Genetics, Johns Hopkins University (Baltimore, MD) and National Center for Biotechnology Information, National Library of Medicine (Bethesda, MD); World Wide Web URL: http://www3.ncbi.nlm.nih.gov/omim.
Pease, A.C.; Solas, D.; Sullivan, E.J.; Cronin, M.T.; Holmes, C.P.; Fodor, S.P.A. (1994), ‘Light Generated OH-gonucleotide Arrays for Rapid DNA Sequence Analysis’, Proceedings of the National Academy of Sciences, Vol. 91, pp. 5022–5026.
Pokorski, R. (1994), ‘Use of Genetic Information by Private Insurers’ in Murphy, T.; Lappe, M. (eds.), Justice and the Human Genome Project University of California Press, Berkeley, pp. 91–109.
Raab, Selwyn (1996), ‘N.J. Officials Say Mob Ring Infiltrated Health Care’, New York Times, 21 August, pp. A1, C19.
Silverman, Paul H. (1995), ‘Commerce and Genetic Diagnostics’, Hastings Center Report, Vol. 25No. 3 Supplement, pp. S15–S18.
Stone, Richard (1993), ‘Biotech Sails into Heavy Financial Seas’, Science, Vol. 260,No. 5110, 14 May, pp. 908–910.
Task Force on Genetic Information and Insurance (1993), Genetic Information and Health Insurance: Report of the Task Force on Genetic Information and Health Insurance National Institutes of Health, Washington, D.C.
Wade, Nicholas (1997), ‘Where Computers and Biology Meet: Making a DNA Chip’, New York Times, 8 April, p. C1.
Wadman, M. (1996), ‘Drug Company’ suppressed’ Publication of Resaerch [news]’, Nature, Vol. 381,No. 6577, 2 May, p. 4.
Watson, James D. (1990), ‘The Human Genome Project-Past, Present, and Future’, Science, Vol. 248, pp. 44–49.
Watson, James D. (1992), ‘A Personal View of the Project’ Kevles, in Daniel J.; Hood, Leroy (eds.), The Code of Codes: Scientific and Social Issues in the Human Genome Project Harvard University Press, Cambridge, pp. 164–176.
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 1999 Kluwer Academic/Plenum Publishers
About this chapter
Cite this chapter
Naser, C.R. (1999). High Speed Genetic Testing Technology and the Computerization of the Medical Record. In: Thompson, A.K., Chadwick, R.F. (eds) Genetic Information. Springer, Boston, MA. https://doi.org/10.1007/978-0-585-34586-4_10
Download citation
DOI: https://doi.org/10.1007/978-0-585-34586-4_10
Publisher Name: Springer, Boston, MA
Print ISBN: 978-0-306-46052-4
Online ISBN: 978-0-585-34586-4
eBook Packages: Springer Book Archive